Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Chemiphar Revises Forecasts Up Following Q3 Performance
Japanese Generics Firm Finally Shaking Off Impact Of NHI Revision And COVID-19
Feb 25 2022
•
By
Chloe Kent
Nippon Chemiphar has revised its forecast up • Source: Alamy
More from Earnings
More from Business